Study to Evaluate the Safety and Efficacy of CSB-001 Ophthalmic Solution 0.1% in Neurotrophic Keratitis Subjects
Clinical trial NCT04909450 · COMPLETED
Trial details
- NCT number
- NCT04909450
- Sponsor
- Claris Biotherapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-24
- Primary completion
- 2024-05-07
- Enrollment
- 131
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.